Mylan CEO faces backlash over skyrocketing pricing for the EpiPen. Estimated to bring in over $1.1 billion in revenue, marketing costs are only estimated at $85 million.
Read the full story at : http://www.cbsnews.com/news/epipen-price-hike-mylan-ceo-heather-bresch-testifies-congress-documents-profit/
